Status:
COMPLETED
Acetaminophen (APAP) +/- Oxycodone
Lead Sponsor:
Montefiore Medical Center
Conditions:
Musculoskeletal Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is an emergency department based randomized study of oxycodone/ acetaminophen versus acetaminophen alone for patients with acute musculoskeletal pain refractory to ibuprofen
Eligibility Criteria
Inclusion
- Acute musculoskeletal pain: Any pain attributable to muscles, bones, joints, tendons, ligaments or supporting structures, as determined by the clinical team, of 10 days duration or less. Prior to the onset of acute pain, patients cannot have experienced pain in the same body region during the prior six months
- Pain has to be described as moderate or severe, when the patient is asked if the pain is mild, moderate or severe in intensity
Exclusion
- Use of an non-steroidal anti-inflammatory drug within the previous six hours
- Use of acetaminophen within the previous six hours
- Use of an opioid within the previous ten days
- Chronic pain, defined as any pain on \>50% of days for at least 3 months prior to onset of acute pain
- Gout
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
393 Patients enrolled
Trial Details
Trial ID
NCT04122443
Start Date
December 1 2019
End Date
July 31 2022
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467